Keys To Accessible Cytology Screening: How AI Is Bridging the Gap (Zoetis)

Keys To Accessible Cytology Screening: How AI Is Bridging the Gap (Zoetis)

Sunday, January 18, 2026 3:00 PM to 3:25 PM · 25 min. (America/New_York)
OCCC Expo Hall
West Learning Theater Booth #300

Information

Explore the impact of AI-driven cytology in veterinary diagnostics. This course covers sample preparation and how the Vetscan Imagyst® system's AI Masses indication quickly identifies cancer-suggestive cells, helping veterinarians make timely treatment decisions and improve patient care.​
Program
VMX Learning Theater West (Sunday)
CE Credit
0.5
Primary Discipline
Small Animal
Secondary Discipline
General
Learning Level
Intermediate
One Day Access
Sunday
RACE Credit Type
Medical
Zoetis1908As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees.

Registered attendees

Beth Venit
Beth Venit
Chief Veterinary OfficerAmerican Association of Veterinary State Boards
Kristin Owens
Kristin Owens
Dr.ZOETIS
Laurie Rankin
Laurie Rankin
Sr Veterinary L&D TrainerChewy